This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

3 Stocks Spiking on Big Volume

Myriad Genetics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

Myriad Genetics (MYGN - Get Report) is engaged in the discovery and commercialization of transformative tests which assess a person's risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence. This stock is trading up 5.9% at $27.66 in recent trading.

Today's Volume: 2.39 million

Average Volume: 988,282

Volume % Change: 192%

Shares of MYGN are spiking higher here after the Supreme Court concluded its debate over whether Myriad Genetics and other gene-based biopharmaceutical or diagnostic companies could patent human DNA.

>>2 Biotech Stocks Under $10 to Watch

From a technical perspective, MYGN is exploding higher here back above its 200-day moving average at $26.43 with heavy upside volume. This move is quickly pushing shares of MYGN within range of triggering a major breakout trade. That trade will hit if MYGN manages to take out some near-term overhead resistance levels at $27.83 to $27.89 with high volume.

Traders should now look for long-biased trades in MYGN as long as it's trending above its 200-day at $26.43, and then once it sustains a move or close above those breakout levels with volume that hits near or above 988,282 shares. If that breakout triggers soon, then MYGN will set up to re-test or possibly take out its next major overhead resistance levels at $30 to its 52-week high at $31.80.
2 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
C $54.09 -0.22%
MYGN $43.50 -1.34%
PBYI $75.30 0.70%
AAPL $118.30 0.42%
FB $104.24 -1.15%


Chart of I:DJI
DOW 17,719.92 -78.57 -0.44%
S&P 500 2,080.41 -9.70 -0.46%
NASDAQ 5,108.6660 -18.8590 -0.37%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs